Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis

Author： Saad Amr A   Hyrich Kimme L   Ashcroft Darren M  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.2, 2011-03, pp. : 219-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature

By Birnbaum Howard   Shi Lizheng   Pike Crystal   Kaufman Rebecca   Sun Peter   Cifaldi Mary  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 255-269

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF Treatment in Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3141-3151

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-TNF- Antibody Therapies in Autoimmune Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 16, 2006-08 ,pp. : 1707-1714

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

By Coenen Marieke JH   Toonen Erik JM   Scheffer Hans   Radstake Timothy RDJ   Barrera Pilar   Franke Barbara  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 761-773

Future Medicine

Access to resources Recommend Favorite

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

By Avouac J   Allanore Y  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1121-1128

Informa Healthcare

Access to resources Recommend Favorite